US Patent 9517276 Compositions and methods for conjugating activatable antibodies
Patent 9517276 was granted and assigned to CytomX Therapeutics on December, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 4, 2014
Date of Patent
December 13, 2016
Patent Applicant
Patent Application Number
14296207
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9517276 Compositions and methods for conjugating activatable antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.